NO20064819L - Trisyklisk benzopyranforbindelse - Google Patents

Trisyklisk benzopyranforbindelse

Info

Publication number
NO20064819L
NO20064819L NO20064819A NO20064819A NO20064819L NO 20064819 L NO20064819 L NO 20064819L NO 20064819 A NO20064819 A NO 20064819A NO 20064819 A NO20064819 A NO 20064819A NO 20064819 L NO20064819 L NO 20064819L
Authority
NO
Norway
Prior art keywords
group
hydrogen atom
ring
atom
bond
Prior art date
Application number
NO20064819A
Other languages
English (en)
Other versions
NO339495B1 (no
Inventor
Kazuhiko Ohrai
Yukihiro Shigeta
Tomoyuki Matsuda
Osamu Uesugi
Takumi Okada
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of NO20064819L publication Critical patent/NO20064819L/no
Publication of NO339495B1 publication Critical patent/NO339495B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Denne oppfinnelsen vedrører benzopyranderivater med formel (I) eller (II), eller farmasøytisk akseptable salter derav hvori R' og R2 uavhengig av hverandre er hydrogenatom, Cl-6 alkylgruppe eller C6-14 arylgruppe, R3 er hydrogenatom eller Cl-6 alkylkarbonyloksygruppe, eller sammen med R4 danner en binding, R4 er hydrogenatom, eller sammen med R3 danner en binding, m er et heltall fra 0 til 4, n er et heltall fra 0 til 4, V er en enkeltbinding, CR7R8, NR9, 0, S, SO eller S02, R5 er hydrogenatom eller Cl-6alkylgruppe, R6 er hydrogenatom, C l-6 alkylgruppe, C3-8 cykloalkylgruppe, C3-8cykloalkenylgruppe, aminogruppe, Cl-6 alkylaminogruppe, diC l-6 alkylaminogruppe, C6-14 arylaminogruppe, C2-9 heteroarylaminogruppe, C6-14 arylgruppe, C2-9 heteroarylgruppe eller C2-9 heterocyklylgruppe, A er 5-, 6- eller 7-leddet ring fusjonert med benzenring, som komponentatomer i ringen kan oksygenatom, nitrogenatom eller svovelatom være inkludert i et antall av 1 til 3 alene eller i kombinasjon derav, antallet av umettede bindinger i ringen er 1, 2 eller 3 inklusive en umettet binding av benzenringen som fusjoneres, karbonatomer som utgjør ringen kan være karbonyl eller tiokarbonyl. Disse forbindelsene er anvendbare som et anti-arytmisk middel.
NO20064819A 2004-03-23 2006-10-23 Trisyklisk benzopyranforbindelse NO339495B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004084605 2004-03-23
PCT/JP2005/006004 WO2005090357A1 (en) 2004-03-23 2005-03-23 Tricyclic benzopyran compound as anti-arrhythmic agents

Publications (2)

Publication Number Publication Date
NO20064819L true NO20064819L (no) 2006-10-23
NO339495B1 NO339495B1 (no) 2016-12-19

Family

ID=34962589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064819A NO339495B1 (no) 2004-03-23 2006-10-23 Trisyklisk benzopyranforbindelse

Country Status (31)

Country Link
US (2) US7652008B2 (no)
EP (1) EP1732929B1 (no)
JP (1) JP4840594B2 (no)
KR (2) KR101085979B1 (no)
CN (3) CN102190661B (no)
AT (1) ATE485299T1 (no)
AU (2) AU2005223612B2 (no)
BR (1) BRPI0508768A (no)
CA (1) CA2558139C (no)
CY (1) CY1111250T1 (no)
CZ (1) CZ2006598A3 (no)
DE (1) DE602005024245D1 (no)
DK (1) DK1732929T3 (no)
EG (1) EG27163A (no)
ES (1) ES2353021T3 (no)
HK (1) HK1099299A1 (no)
HR (1) HRP20110005T1 (no)
IL (1) IL177950A (no)
MX (1) MXPA06010880A (no)
NO (1) NO339495B1 (no)
NZ (2) NZ585606A (no)
PL (1) PL1732929T3 (no)
PT (1) PT1732929E (no)
RS (1) RS51742B (no)
RU (1) RU2380370C2 (no)
SI (1) SI1732929T1 (no)
SK (1) SK287994B6 (no)
TW (1) TWI352704B (no)
UA (1) UA91189C2 (no)
WO (1) WO2005090357A1 (no)
ZA (1) ZA200607388B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005223612B2 (en) * 2004-03-23 2010-06-24 Nissan Chemical Industries, Ltd. Tricyclic benzopyran compound as anti-arrhythmic agents
KR20080112290A (ko) 2006-03-10 2008-12-24 닛산 가가쿠 고교 가부시키 가이샤 광학 활성 크로멘 옥사이드화합물의 제조 방법
TW201022223A (en) * 2008-08-14 2010-06-16 Nissan Chemical Ind Ltd Di-substituted benzopyrane compound
JP5664870B2 (ja) * 2009-04-30 2015-02-04 日産化学工業株式会社 3環性ベンゾピラン化合物の新規な結晶形態及びその製造方法
EP3309151A1 (en) 2009-06-25 2018-04-18 Alkermes Pharma Ireland Limited Heterocyclic compounds for the treatment of neurological and psychological disorders
CN104507948B (zh) * 2012-09-27 2017-05-03 日产化学工业株式会社 含氮杂环n‑氧化物化合物的制造方法
IN2015DN03012A (no) * 2012-09-27 2015-10-02 Nissan Chemical Ind Ltd
JPWO2015012271A1 (ja) * 2013-07-25 2017-03-02 日産化学工業株式会社 複素環化合物の製造方法
KR102009756B1 (ko) * 2017-01-06 2019-08-12 고려대학교 세종산학협력단 신규한 퀴놀리논 유도체 및 이를 유효성분으로 포함하는 천식 또는 아토피 등의 알러지성 질환의 예방 또는 치료용 약학 조성물
CA3092335A1 (en) 2018-03-05 2019-09-12 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN108727261B (zh) * 2018-06-21 2021-09-24 济南大学 一种硝基取代喹那啶的制备方法
EP3903882A4 (en) 2018-12-28 2022-09-21 Osaka University THERAPEUTIC AGENT FOR INHERITED BRADYARRHYTHMIA
RU2754610C1 (ru) * 2020-04-14 2021-09-03 Георгий Викторович ТЕЦ Препарат для лечения заболеваний, вызванных бактериями
JPWO2021261598A1 (no) * 2020-06-26 2021-12-30

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM7682A1 (en) 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
JPS5867683U (ja) 1981-10-28 1983-05-09 株式会社ナムコ 歩行ロボツト
JPH0699439B2 (ja) * 1988-02-03 1994-12-07 日産化学工業株式会社 ピラノベンゾオキサジアゾール誘導体
JP2658198B2 (ja) * 1988-06-23 1997-09-30 日産化学工業株式会社 ピラノベンゾトリアゾール誘導体
US5097037A (en) 1989-07-17 1992-03-17 Nissan Chemical Industries, Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
JP2876712B2 (ja) * 1989-07-17 1999-03-31 日産化学工業株式会社 光学活性ピラノベンゾオキサジアゾール誘導体
US5164509A (en) * 1990-11-26 1992-11-17 E. R. Squibb & Sons, Inc. Benzodiazolo analogs
TW384291B (en) 1993-04-02 2000-03-11 Nissan Chemical Ind Ltd Compounds for reinforcing the contraction of cardiac muscles and reducing the rate of heart beats
JPH07300414A (ja) * 1993-04-02 1995-11-14 Nissan Chem Ind Ltd 心不全治療薬
JP2734457B2 (ja) 1994-02-23 1998-03-30 日産化学工業株式会社 不斉エポキシ化反応
DE69518322T2 (de) * 1994-06-10 2001-02-15 Smithkline Beecham Plc C-4 amid substituierte verbindungen und deren verwendung als therapeutische mittel
SK283837B6 (sk) * 1996-05-15 2004-03-02 Hoechst Aktiengesellschaft Chrómany, spôsob ich prípravy, liečivá, ktoré ich obsahujú, a ich použitie
DE69921815T2 (de) 1998-06-03 2005-11-10 Nissan Chemical Industries, Ltd. Indanderivate
WO2000012492A1 (en) 1998-09-01 2000-03-09 Nissan Chemical Industries, Ltd. Benzoxazine derivatives
AU2830800A (en) 1999-03-25 2000-10-16 Nissan Chemical Industries Ltd. Chroman derivatives
CZ2002802A3 (cs) 1999-09-17 2003-02-12 Nissan Chemical Industries, Ltd. Benzopyranové deriváty
US6555574B1 (en) 1999-09-24 2003-04-29 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
US6677371B1 (en) 1999-10-05 2004-01-13 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
NZ529916A (en) 2001-06-25 2005-04-29 Nissan Chemical Ind Ltd Substituted benzopyran derivatives against arrhythmia
WO2003014113A1 (en) 2001-08-06 2003-02-20 Glenmark Pharmaceuticals Limited Novel benzopyran compounds and process for their preparation and use
AU2005223612B2 (en) * 2004-03-23 2010-06-24 Nissan Chemical Industries, Ltd. Tricyclic benzopyran compound as anti-arrhythmic agents

Also Published As

Publication number Publication date
US7652008B2 (en) 2010-01-26
CN1934116B (zh) 2012-10-10
CN102190661B (zh) 2013-07-31
RU2380370C2 (ru) 2010-01-27
US7964623B2 (en) 2011-06-21
CZ2006598A3 (cs) 2006-11-15
BRPI0508768A (pt) 2007-02-27
KR101019402B1 (ko) 2011-03-07
KR20100130249A (ko) 2010-12-10
EG27163A (en) 2015-08-24
TWI352704B (en) 2011-11-21
WO2005090357A1 (en) 2005-09-29
ATE485299T1 (de) 2010-11-15
ES2353021T3 (es) 2011-02-24
PL1732929T3 (pl) 2011-04-29
CN101429200A (zh) 2009-05-13
AU2010202900A1 (en) 2010-07-29
CA2558139C (en) 2012-01-17
SK50792006A3 (sk) 2007-09-06
ZA200607388B (en) 2008-07-30
DE602005024245D1 (de) 2010-12-02
CN101429200B (zh) 2012-05-30
SI1732929T1 (sl) 2010-12-31
MXPA06010880A (es) 2006-12-15
JP2007530436A (ja) 2007-11-01
AU2005223612A1 (en) 2005-09-29
NZ585606A (en) 2011-11-25
HRP20110005T1 (hr) 2011-02-28
SK287994B6 (sk) 2012-09-03
US20100069374A1 (en) 2010-03-18
RS51742B (en) 2011-10-31
PT1732929E (pt) 2010-12-21
DK1732929T3 (da) 2010-12-20
CY1111250T1 (el) 2015-06-11
AU2005223612B2 (en) 2010-06-24
TW200600509A (en) 2006-01-01
EP1732929B1 (en) 2010-10-20
NO339495B1 (no) 2016-12-19
RU2006137284A (ru) 2008-04-27
AU2010202900B2 (en) 2011-10-27
HK1099299A1 (en) 2007-08-10
NZ549570A (en) 2010-08-27
IL177950A0 (en) 2006-12-31
CN102190661A (zh) 2011-09-21
IL177950A (en) 2013-04-30
CA2558139A1 (en) 2005-09-29
KR20070009638A (ko) 2007-01-18
UA91189C2 (en) 2010-07-12
US20080004262A1 (en) 2008-01-03
JP4840594B2 (ja) 2011-12-21
CN1934116A (zh) 2007-03-21
KR101085979B1 (ko) 2011-11-22
EP1732929A1 (en) 2006-12-20

Similar Documents

Publication Publication Date Title
NO20064819L (no) Trisyklisk benzopyranforbindelse
BG107120A (en) Novel, slow-acting betamimetics, a method for their production and their use as medicaments
MY139988A (en) Macrocylic inhibitors of hepatitis c virus
CY1109222T1 (el) Παραγωγο συγχωνευμενης κινολινης και χρηση του
CA2158855A1 (en) Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents
HUP0102723A2 (hu) Új difenilkarbamid-származékok, eljárás előállításukra és ezeket tartalmazó gyógyászati készítmények
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
ES2199696A1 (es) Mezclas de estabilizantes
HUP0203839A2 (hu) 4-Fenil-1-piperazinil-, -piperidinil- és tetrahidropiridil-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE69525763T2 (de) 4,6-DI-t-BUTYL-2,3-DIHYDROBENZOTHIOPHENE, DIE LDL OXIDATION HEMMEN
DE69926776D1 (de) Quinalozinon-derivate
MXPA01013148A (es) Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico.
EA199901050A2 (ru) Новые соединения имидазолина, способ их получения и содержащие их фармацевтические композиции
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
MXPA02007973A (es) Compuestos de aminoacidos y su uso como inhibidores de nep, ace y ece.
IL136510A (en) Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same
ATE328954T1 (de) Stabilisatormischung
EP0999211A4 (en) PURINE DERIVATIVES AND THEIR MEDICINAL APPLICATION
DK1546096T3 (da) Fremgangsmåde til fremstilling af aminopyrrolidinderivater
ATE502034T1 (de) Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung
DK1200442T3 (da) Derivater af 2,3-benzodiazepin
TH25178B (th) สารประกอบประเภทใหม่
TH61861A3 (th) 4-ออกโซ-1,4-ไดไฮโดร-3-ควิโนลีนคาร์บอกซามีดที่เป็นตัวกระทำต้านเชื้อไวรัส
UY26245A1 (es) Nuevos derivados de aminotiazoles, su preparacion y las composiciones farmaceuticas que los contienen art 127 de la ley 17164

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees